Navigation Links
Healing wounds with lasers, vehicles that drive themselves, other cutting-edge optics
Date:5/26/2009

age point of 425 miles in space, the 4,300-pound GeoEye-1 satellite orbits the Earth and focuses its powerful lens on the surface below, snapping electronic images that can resolve objects on the ground as small as 41 cm across (16 inches). That's approximately the size of home plate on a baseball diamond. These images are typically processed and sold to the military for mapping and to companies like Google, which makes them available to the public through its platform Google Earth. (Because of federal regulations, the publicly-available images are slightly lower resolution -- approximately 50 cm).

In Baltimore at next week's CLEO/IQEC, GeoEye's Systems Engineering Director Michael Madden will describe some of the satellite's key features, such as the fact that it's the first commercial satellite with military-grade star trackers, which along with GPS makes the imagery from the satellite very accurate -- an important aspect for making precise maps. He will also preview the satellite GeoEye-2, which is expected to be launched around 2012 and would have a ground resolution twice as fine as GeoEye-1.

These powerful public eyes in the sky have already had an impact. Madden says for instance, a researcher at the University of California, San Diego is using satellite imagery to search for the tomb of Genghis Khan in Mongolia. A few months ago, one of the enduring photos taken during U.S. President Barack Obama's inauguration was the image captured by GeoEye-1 of the National Mall in Washington, D.C., which showed throngs of people crowded together. In March 2009, the GeoEye-1 satellite captured a close-up image of a North Korean missile sitting on the launch pad just 25 minutes before launch. GeoEye-1 also provided a look at the annual Cherry Blossom Festival held in Washington, D.C. From the space photo, details were clear enough to resolve individual trees, ripples on the Potomac River, and people and cars crowded along the Tidal Basin, the area in d
'/>"/>

Contact: Colleen Morrison
cmorri@osa.org
202-416-1437
Optical Society of America
Source:Eurekalert

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology news :

1. Stem cell focus for IBD wound healing
2. Research yields potential target for cancer, wound healing and fibrosis
3. Shellfish and inkjet printers may hold key to faster healing from surgeries
4. Advancement in tissue engineering promotes oral wound healing
5. Closing the gap: Journal launch brings together wound-healing knowledge
6. Scientists suspect omega-3 fatty acids could slow acute wound healing
7. Licking your wounds: Scientists isolate compound in human saliva that speeds wound healing
8. Engineer develops detergent to promote peripheral nerve healing
9. Skin care: new research into scar-free healing
10. New treatment boosts bone healing and regrowth
11. New mechanical insights into wound healing and scar tissue formation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... 2014) Scientists at The New York Stem ... closer to creating a viable cell replacement therapy ... , For the first time, NYSCF scientists ... skin samples of patients with primary progressive multiple ... to induce these stem cells into becoming oligodendrocytes, ...
(Date:7/24/2014)... York, NY - July 24, 2014 -- Keryx Biopharmaceuticals, ... from the long-term, randomized, active control Phase 3 study ... iron-based phosphate binder, for the treatment of hyperphosphatemia in ... PERFECTED study (PhosphatE binding and iRon delivery with FErric ... Journal of the American Society of Nephrology ...
(Date:7/24/2014)... YORK, NY (July 24, 2014) Scientists at ... Institute are one step closer to creating a ... a patient,s own cells. , For the ... (iPS) cells lines from skin samples of patients ... developed an accelerated protocol to induce these stem ...
Breaking Biology News(10 mins):NYSCF scientists one step closer to cell therapy for multiple sclerosis patients 2Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 2Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 3Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 4NYSCF scientists 1 step closer to cell therapy for multiple sclerosis patients 2
... Hopkins scientists seems to have discovered an almost-too-easy way to ... potent versions. Their finding, reported this week in Nature, could ... but also other body tissues. What the researchers ... neural stem cells the sort that might be used ...
... The giant panda is not at an evolutionary dead end ... new research involving scientists from Cardiff University. Previous ... requirements and slow reproductive rates have led to a lack ... extinction. Now a study by Professor Michael Bruford ...
... August 23, 2007 On August 16, the Food and ... sold under the brand name Coumadin. The new label suggests ... be safer for patients with variations in two genes, CYP2C9 ... testing, which may be a useful tool in determining appropriate ...
Cached Biology News:When is a stem cell not really a stem cell? 2American College of Medical Genetics responds to new FDA labeling decision for warfarin 2
(Date:7/24/2014)... DUBLIN , July 24, 2014 ... the "Global Cell Culture Market 2014-2018" report ... Cell culture is the in vitro ... such as research, cell studies, and biopharmaceutical production. Cell ... vaccine production. Cell culture instruments and cell culture consumables ...
(Date:7/24/2014)... Your cell phone may stay charged ... storage capacity. , New research indicates that lithium-ion ... at Lawrence Livermore National Laboratory and ... components will perform as electrodes. , The growing ... for higher-performance batteries. Several key characteristics of lithium-ion ...
(Date:7/24/2014)...  CorMedix Inc. (NYSE MKT: CRMD), a pharmaceutical ... for the prevention and treatment of cardiorenal and ... July 18, 2014 from the NYSE MKT LLC ... plan to regain compliance with continued listing standards ... is continuing the Company,s listing and has granted ...
(Date:7/24/2014)... 2014 2014 Deep Research Report ... a professional and in-depth research report on Potassium ... basic information, including its definition, classification, application, ... research covers the international market analysis, including China’s ... covering macroeconomic environment & economic situation analysis, the ...
Breaking Biology Technology:Global Cell Culture Market 2014-2018: Key Vendors are Becton, Dickinson and Co, EMD, GE Healthcare, Lonza Group, Sigma Aldrich and Thermo Fisher Scientific 2Getting More Life out of Lithium-ion Batteries 2CorMedix, Inc. Granted Extension of NYSE-MKT Listing 2CorMedix, Inc. Granted Extension of NYSE-MKT Listing 3Potassium Sulphate Market & SHMP Industry 2014 (Global, China) Analysis Now Available at DeepResearchReports.com 2Potassium Sulphate Market & SHMP Industry 2014 (Global, China) Analysis Now Available at DeepResearchReports.com 3Potassium Sulphate Market & SHMP Industry 2014 (Global, China) Analysis Now Available at DeepResearchReports.com 4
... , , ROCKVILLE, Md., ... has announced that 263 regulatory professionals achieved Regulatory Affairs ... RAC credential is administered by RAPS and is the ... product sector. , , (Logo: ...
... BEIJING, Sept. 4 /PRNewswire-Asia/ -- ... provider of biopharmaceutical products in China, announced today that,the ... Republic,of China has issued the initial order to Sinovac ... to the initial order, Sinovac is,required to complete the ...
... September 4 Karolinska Development (publ),today announced that one ... clinical study of its candidate drug, tafoxiparin, a,new drug ... promising results of the Phase II trial bring the ... strategy. , Dilafor,s candidate drug, ...
Cached Biology Technology:263 Regulatory Professionals Achieve RAC Certification 2263 Regulatory Professionals Achieve RAC Certification 3Sinovac Obtains Initial Order of H1N1 Vaccine from Chinese Central Government 2Sinovac Obtains Initial Order of H1N1 Vaccine from Chinese Central Government 3Karolinska Development Portfolio Company Completes Successful Phase II Clinical Trial 2Karolinska Development Portfolio Company Completes Successful Phase II Clinical Trial 3
Request Info...
supplied with 10x reaction buffer...
... from yeast/leuconostoc overproducer ATP: ... EC 2.7.1.1/1.1.1.49. One unit of ... of D-glucose in 1 min ... One unit of G6P-DH will ...
Request Info...
Biology Products: